Dr. Neil Datta, MD

Dr. Datta practices at CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance.

Dr. Datta's NPI, 1760893325, was assigned on May 16, 2014. Dr. Datta graduated from Boston University School of Medicine in 2014. Dr. Datta holds Massachusetts license 275276.

Dr. Datta's primary practice is CHA Cambridge Hospital, at 1493 Cambridge Street, Cambridge, MA 02139 in Middlesex County. The practice phone is (617) 665-1000.

Dr. Datta's primary practice is CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance. The medical group on file is Cambridge Health Alliance. Dr. Datta's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Datta practices. Vendor and product names are available with a free account.

Neurology is Dr. Datta's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Datta is licensed in Massachusetts.

CMS data shows 145 Medicare services from Dr. Datta across 6 procedure codes in 2024, for 119 Medicare patients. Medicare paid $13,446 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 119 Medicare patients who saw Dr. Datta in 2024. The largest group is 65 to 74, with 48 patients. 66% of them have high blood pressure, and 57% have high cholesterol. 69% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Datta's median patient age at 52, with 62% women.

In 2024, Dr. Datta wrote 439 Medicare Part D claims for 70 patients. 87% of them were for generic drugs. CMS names the drug for 309 of them, across 12 drugs with 11 or more claims each, at $24,788 in total drug cost. In 2023, CMS named 253 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Datta for performance year 2024, reported as part of a group. Dr. Datta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Datta as offering telehealth.

Dmand AI links 8 papers to Dr. Datta, published from 2011 to 2020. 2017 was the busiest year, with 2. The most frequent topics are Thrombolytic Therapy. Dr. Datta's most frequent co-authors are Amre M. Nouh, MD, Ximena Arcila-Londono, MD and Ekaterina Bakradze, MD.

CMS Open Payments shows 10 general payments to Dr. Datta from 7 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 95% of the total. Genentech, Inc. paid the most, $210.

Dr. Datta graduated from Boston University School of Medicine in 2014.